HomeGeneticsCondition22q11.2 duplication
Back to Condition
22q11.2 duplication
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

22q11.2 duplication

22q11.2 duplication is a genetic condition caused by an extra copy of a small piece of chromosome 22, leading to highly variable features that can include developmental delay and intellectual disability, though many affected individuals show no apparent disabilities.

Overview

22q11.2 duplication is a condition caused by an extra copy of a small piece of chromosome 22. The duplication occurs near the middle of the chromosome at a location designated q11.2.

The features of this condition vary widely, even among members of the same family. Affected individuals may have developmental delay, intellectual disability, slow growth leading to short stature, and weak muscle tone (hypotonia). Many people with the duplication have no apparent physical or intellectual disabilities.

Frequency

The prevalence of the 22q11.2 duplication in the general population is difficult to determine. Because many individuals with this duplication have no associated symptoms, their duplication may never be detected.

Most people tested for the 22q11.2 duplication have come to medical attention as a result of developmental delay or other problems affecting themselves or a family member. In one study, about 1 in 700 people tested for these reasons had the 22q11.2 duplication. Overall, more than 60 individuals with the duplication have been identified.

Causes

People with 22q11.2 duplication have an extra copy of genetic material at position q11.2 on chromosome 22. In most cases, this extra genetic material consists of a sequence of about 3 million DNA building blocks (base pairs), also written as 3 megabases (Mb).

The 3 Mb duplicated region contains 30 to 40 genes. For many of these genes, little is known about their function. A small percentage of affected individuals have a shorter duplication in the same region. Researchers are working to determine which duplicated genes may contribute to the developmental delay and other problems that sometimes affect people with this condition.

Learn more about the chromosome associated with 22q11.2 duplication

  • chromosome 22

Inheritance

The inheritance of 22q11.2 duplication is considered autosomal dominant because the duplication affects one of the two copies of chromosome 22 in each cell. About 70 percent of affected individuals inherit the duplication from a parent. In other cases, the duplication is not inherited and instead occurs as a random event during the formation of reproductive cells (eggs and sperm) or in early fetal development. These affected people typically have no history of the disorder in their family, although they can pass the duplication to their children.

Other Names

  • Chromosome 22q11.2 duplication syndrome
  • Chromosome 22q11.2 microduplication syndrome

Frequently Asked Questions

Because symptoms are so variable, 22q11.2 duplication is often diagnosed when a family member is tested due to developmental delays or other issues, or sometimes incidentally during genetic testing for unrelated reasons. The wide spectrum of features means that prognosis is highly individualized; some individuals may have significant challenges requiring lifelong support, while others may live without ever knowing they have the duplication or experiencing any noticeable effects.
Common challenges can include developmental delays, intellectual disability, weak muscle tone (hypotonia), and slow growth leading to short stature. Support typically involves early intervention programs, physical therapy, occupational therapy, speech therapy, and individualized educational plans to help address specific needs and maximize potential.
Yes, 22q11.2 duplication can be inherited. About 10-15% of cases are inherited from a parent who also has the duplication, even if that parent shows no symptoms. The remaining cases occur spontaneously. If a person has the duplication, there is a 50% chance of passing it on to each child. Genetic counseling is highly recommended for affected individuals and their families to understand inheritance patterns and reproductive options.
Medical monitoring is tailored to the individual's symptoms but generally includes regular developmental assessments to track progress and identify areas needing support. Depending on specific concerns, follow-up may involve specialists such as neurologists, geneticists, physical therapists, and endocrinologists to address issues like hypotonia, growth, or learning difficulties.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab